Bylvay (odevixibat) / Albireo, Ipsen 
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bylvay (odevixibat) / Ipsen
ASSERT, NCT04674761 / 2020-004011-28: Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome

Completed
3
52
Europe, Canada, US, RoW
Odevixibat, A4250, Placebo
Albireo
Alagille Syndrome
09/22
09/22
NCT06258902: Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

Recruiting
N/A
20
US
Ipsen
Pregnancy Related
09/31
09/32

Download Options